{"doc_id": "si-2021-0245-reg-1", "parent_doc_id": "si-2021-0245", "section_id": "reg-1", "section_label": "Regulation 1.", "si_number": "S.I. No. 245 of 2021", "title": "Medicines Board (Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the", "year": 2021, "heading": "1. (1) These Regulations may be cited as the Medicinal Products", "text_raw": "1. (1) These Regulations may be cited as the Medicinal Products \n\n(Prescription and Control of Supply) (Amendment) (No. 7) Regulations 2021. \n\n(2) The collective citation “the Medicinal Products (Prescription and \n\nControl of Supply) Regulations 2003 to 2021” includes these Regulations.", "text_norm": "1 (1) regulation may cited medicinal product (prescription control supply) (amendment) (no 7) regulation 2021 (2) collective citation medicinal product (prescription control supply) regulation 2003 2021 includes regulation", "start_char": 642, "end_char": 932, "source_path": "downloads\\2021\\2021_0245.pdf", "extraction_method": "pdfminer", "checksum": "sha256:dc8272cc533c74279613db122738a29b3d13e064612f3a11db39aecf8bc96504", "cross_refs": []}
{"doc_id": "si-2021-0245-reg-2", "parent_doc_id": "si-2021-0245", "section_id": "reg-2", "section_label": "Regulation 2.", "si_number": "S.I. No. 245 of 2021", "title": "Medicines Board (Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the", "year": 2021, "heading": "In these Regulations—", "text_raw": "2. \n\nIn these Regulations— \n\n“Principal Regulations” means the Medicinal Products (Prescription and \nControl of Supply) Regulations 2003 (S.I. No. 540 of 2003); \n\n“Regulations (No. 4) of 2021” means the Medicinal Products (Prescription and \nControl of Supply) (Amendment) (No. 4) Regulations 2021 (S.I. No. 155 of \n2021); \n\n“Regulations (No. 6) of 2021” means the Medicinal Products (Prescription and \nControl of Supply) (Amendment) (No. 6) Regulations 2021 (S.I. No. 81 of \n2021).", "text_norm": "2 regulations-- principal regulation mean medicinal product (prescription control supply) regulation 2003 (s.i no 540 2003) regulation (no 4) 2021 mean medicinal product (prescription control supply) (amendment) (no 4) regulation 2021 (s.i no 155 2021) regulation (no 6) 2021 mean medicinal product (prescription control supply) (amendment) (no 6) regulation 2021 (s.i no 81 2021)", "start_char": 932, "end_char": 1416, "source_path": "downloads\\2021\\2021_0245.pdf", "extraction_method": "pdfminer", "checksum": "sha256:dc8272cc533c74279613db122738a29b3d13e064612f3a11db39aecf8bc96504", "cross_refs": []}
{"doc_id": "si-2021-0245-reg-3", "parent_doc_id": "si-2021-0245", "section_id": "reg-3", "section_label": "Regulation 3.", "si_number": "S.I. No. 245 of 2021", "title": "Medicines Board (Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the", "year": 2021, "heading": "3. Regulation 4F (as amended by Regulation 4 of the Regulations (No. 4)", "text_raw": "3. Regulation 4F (as amended by Regulation 4 of the Regulations (No. 4) \nof 2021) of the Principal Regulations is amended by substituting for \nsubparagraph (b) the following: \n\n“(b) the person supplying and administering the medicinal product is— \n\n(i) \n\na registered nurse (including a registered midwife), \n\n(ii) a registered pharmacist, \n\n(iii) an advanced paramedic, \n\n(iv) a paramedic, \n\n(v) \n\nan emergency medical technician, \n\nNotice of the making of this Statutory Instrument was published in \n“Iris Oifigiúil” of 21st May, 2021. \n\n \n \n \n \n \n \n \n \n \n \n \n\f[245] 3 \n\n(vi) a person registered in the register of the Physiotherapists \nRegistration Board established under section 36(1)(a) of the \nHealth and Social Care Professionals Act 2005 (No. 27 of \n2005), \n\n(vii) a registered optometrist, \n\n(viii) a registered dentist, \n\n(ix) a person registered in the register of the Radiographers \nRegistration Board established under section 36(1)(a) of the \nHealth and Social Care Professionals Act 2005, or \n\n(x) \n\nthe register of dental hygienists \na person registered \nestablished and maintained by the Dental Council under section \n53 of the Dentists Act 1985, \n\nin \n\nand has received training in the administration of the product, as \napproved by the regulatory body for the profession concerned, or, in the \ncase of a regulatory body that does not have legal authority to approve \nsuch training, as approved by the Health Service Executive following \nconsultation with the regulatory body,”.", "text_norm": "3 regulation 4f (as amended regulation 4 regulation (no 4) 2021) principal regulation amended substituting subparagraph (b) following (b) person supplying administering medicinal product is-- (i) registered nurse (including registered midwife) (ii) registered pharmacist (iii) advanced paramedic (iv) paramedic (v) emergency medical technician notice making statutory instrument published iris oifigiuil 21st may 2021 245 3 (vi) person registered register physiotherapist registration board established section 36(1)(a) health social care professional act 2005 (no 27 2005) (vii) registered optometrist (viii) registered dentist (ix) person registered register radiographer registration board established section 36(1)(a) health social care professional act 2005 (x) register dental hygienist person registered established maintained dental council section 53 dentist act 1985 received training administration product approved regulatory body profession concerned case regulatory body legal authority approve training approved health service executive following consultation regulatory body", "start_char": 1416, "end_char": 2916, "source_path": "downloads\\2021\\2021_0245.pdf", "extraction_method": "pdfminer", "checksum": "sha256:dc8272cc533c74279613db122738a29b3d13e064612f3a11db39aecf8bc96504", "cross_refs": []}
{"doc_id": "si-2021-0245-reg-4", "parent_doc_id": "si-2021-0245", "section_id": "reg-4", "section_label": "Regulation 4.", "si_number": "S.I. No. 245 of 2021", "title": "Medicines Board (Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the", "year": 2021, "heading": "4. The Principal Regulations are amended by inserting after Regulation 4F", "text_raw": "4. The Principal Regulations are amended by inserting after Regulation 4F \n(as amended by Regulation 4 of the Regulations (No. 4) of 2021) the following \nRegulation: \n\n“Administration of Covid-19 vaccinations by students \nprofessions \n\nin health \n\n4G. It shall not be a contravention of a provision of these Regulations for \na person to administer to another person a medicinal product specified in \ncolumn 1 of the Twelfth Schedule (other than epinephrine (adrenaline) \ninjection) if, and only if— \n\n(a) the medicinal product is administered as part of the vaccination \nprogramme implemented in the State to address the Covid-19 \nemergency, \n\n(b) the medicinal product is administered in accordance with the \n\ndirections of a registered medical practitioner, \n\n(c) the person administering the medicinal product is a student in— \n\n(i) \n\n(ii) \n\na programme of basic medical education and training \napproved by the Medical Council under section 88(2) of \nthe Medical Practitioners Act 2007, \n\na Masters degree in pharmacy recognised and approved by \nthe Pharmaceutical Society of Ireland under Regulation 6 \nof the Pharmaceutical Society of Ireland (Education and \nTraining) (Integrated Course) Rules 2014 (S.I. No. 377 of \n2014), \n\n \n \n \n \n\f4 [245] \n\n(iii) \n\n(iv) \n\n(v) \n\n(vi) \n\na programme of nursing or midwifery education and \ntraining approved by the Nursing and Midwifery Board of \nIreland under section 85(2) of the Nurses and Midwives \nAct 2011, \n\na course leading to a primary qualification in dentistry \nlisted in the Second Schedule to the Dentists Act 1985, \n\ntraining programme \na physiotherapy education and \napproved by the Physiotherapists Registration Board \nunder section 48 of \nthe Health and Social Care \nProfessionals Act 2005, or \n\nan optometry education and training programme approved \nby the Optical Registration Board under section 48 of the \nHealth and Social Care Professionals Act 2005, \n\nand has successfully undertaken training in the administration of \nthe product, as approved by the Health Service Executive, \n\n(d) the medicinal product is supplied and administered in a vaccination \ncentre established as part of the programme referred to in paragraph \n(a), and \n\n(e) the product is administered in accordance with the requirements \nspecified in columns 2 to 5 of the Twelfth Schedule opposite the \nmention of the product specified in column 1 of that Schedule.”.", "text_norm": "4 principal regulation amended inserting regulation 4f (as amended regulation 4 regulation (no 4) 2021) following regulation administration covid-19 vaccination student profession health 4g shall contravention provision regulation person administer another person medicinal product specified column 1 twelfth schedule (other epinephrine (adrenaline) injection) if-- (a) medicinal product administered part vaccination programme implemented state address covid-19 emergency (b) medicinal product administered accordance direction registered medical practitioner (c) person administering medicinal product student in-- (i) (ii) programme basic medical education training approved medical council section 88(2) medical practitioner act 2007 master degree pharmacy recognised approved pharmaceutical society ireland regulation 6 pharmaceutical society ireland (education training) (integrated course) rule 2014 (s.i no 377 2014) 4 245 (iii) (iv) (v) (vi) programme nursing midwifery education training approved nursing midwifery board ireland section 85(2) nurse midwife act 2011 course leading primary qualification dentistry listed second schedule dentist act 1985 training programme physiotherapy education approved physiotherapist registration board section 48 health social care professional act 2005 optometry education training programme approved optical registration board section 48 health social care professional act 2005 successfully undertaken training administration product approved health service executive (d) medicinal product supplied administered vaccination centre established part programme referred paragraph (a) (e) product administered accordance requirement specified column 2 5 twelfth schedule opposite mention product specified column 1 schedule", "start_char": 2916, "end_char": 5316, "source_path": "downloads\\2021\\2021_0245.pdf", "extraction_method": "pdfminer", "checksum": "sha256:dc8272cc533c74279613db122738a29b3d13e064612f3a11db39aecf8bc96504", "cross_refs": []}
{"doc_id": "si-2021-0245-reg-5", "parent_doc_id": "si-2021-0245", "section_id": "reg-5", "section_label": "Regulation 5.", "si_number": "S.I. No. 245 of 2021", "title": "Medicines Board (Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the", "year": 2021, "heading": "5. Regulation 10D (as re-numbered by Regulation 3 of the Medicinal", "text_raw": "5. Regulation 10D (as re-numbered by Regulation 3 of the Medicinal \nProducts (Prescription and Control of Supply) (Amendment) (No. 5) \nRegulations 2021 (S.I. No. 130 of 2021)) of the Principal Regulations is \namended— \n\n(a) by inserting “or Regulation 4G” after “(except in the case of \n\nepinephrine (adrenaline))”, and \n\n(b) by substituting for paragraph (f) the following paragraphs: \n\n(c) \n\n“(f) in the case of administration under Regulation 4F, the name, \nbusiness address, email and telephone number of the person who \nsupplied and administered the product and the number of his or \nher certificate of registration issued by his or her professional \nregulatory body; \n\n(fa) in the case of administration under Regulation 4G, the name, \nhome address, email and telephone number of the person who \nadministered the product and, in the case of a nursing or \nmidwifery student, the candidate number attached to his or her \nregistration in the candidate register maintained by the Nursing \nand Midwifery Board of Ireland;”. \n\n \n \n \n \n \n\f[245] 5", "text_norm": "5 regulation 10d (as re-numbered regulation 3 medicinal product (prescription control supply) (amendment) (no 5) regulation 2021 (s.i no 130 2021)) principal regulation amended-- (a) inserting regulation 4g (except case epinephrine (adrenaline)) (b) substituting paragraph (f) following paragraph (c) (f) case administration regulation 4f name business address email telephone number person supplied administered product number certificate registration issued professional regulatory body (fa) case administration regulation 4g name home address email telephone number person administered product case nursing midwifery student candidate number attached registration candidate register maintained nursing midwifery board ireland  245 5", "start_char": 5316, "end_char": 6364, "source_path": "downloads\\2021\\2021_0245.pdf", "extraction_method": "pdfminer", "checksum": "sha256:dc8272cc533c74279613db122738a29b3d13e064612f3a11db39aecf8bc96504", "cross_refs": []}
{"doc_id": "si-2021-0245-reg-6", "parent_doc_id": "si-2021-0245", "section_id": "reg-6", "section_label": "Regulation 6.", "si_number": "S.I. No. 245 of 2021", "title": "Medicines Board (Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the", "year": 2021, "heading": "6. The Eighth Schedule (as amended by Regulation 3 of the Regulations", "text_raw": "6. The Eighth Schedule (as amended by Regulation 3 of the Regulations \n(No. 6) of 2021) to the Principal Regulations is amended, in the entry for the \nmedicinal product “COVID-19 Vaccine AstraZeneca, suspension for injection \nCOVID-19 Vaccine (ChAdOx1-S [recombinant])” (inserted by Regulation 3 of \nthe Regulations of 2021), by substituting “Vaxzevria (also known as COVID19 Vaccine AstraZeneca)” for “COVID-19 Vaccine AstraZeneca” in both \nplaces it occurs.", "text_norm": "6 eighth schedule (as amended regulation 3 regulation (no 6) 2021) principal regulation amended entry medicinal product covid-19 vaccine astrazeneca suspension injection covid-19 vaccine (chadox1-s recombinant ) (inserted regulation 3 regulation 2021) substituting vaxzevria (also known covid19 vaccine astrazeneca) covid-19 vaccine astrazeneca place occurs", "start_char": 6364, "end_char": 6826, "source_path": "downloads\\2021\\2021_0245.pdf", "extraction_method": "pdfminer", "checksum": "sha256:dc8272cc533c74279613db122738a29b3d13e064612f3a11db39aecf8bc96504", "cross_refs": []}
{"doc_id": "si-2021-0245-reg-7", "parent_doc_id": "si-2021-0245", "section_id": "reg-7", "section_label": "Regulation 7.", "si_number": "S.I. No. 245 of 2021", "title": "Medicines Board (Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the", "year": 2021, "heading": "7. The Twelfth Schedule (as amended by Regulation 4 of the Regulations", "text_raw": "7. The Twelfth Schedule (as amended by Regulation 4 of the Regulations \n(No. 6) of 2021) to the Principal Regulations is amended, in the entry for the \nmedicinal product “COVID-19 Vaccine AstraZeneca, suspension for injection \nCOVID-19 Vaccine (ChAdOx1-S [recombinant])” (inserted by Regulation 4 of \nthe Regulations of 2021), by substituting “Vaxzevria (also known as COVID19 Vaccine AstraZeneca)” for “COVID-19 Vaccine AstraZeneca” in both \nplaces it occurs. \n\nGIVEN under my Official Seal, \n\n13 May, 2021. \n\nSTEPHEN DONNELLY, \nMinister for Health. \n\n \n \n \n \n \n \n \n \n \n \n \n \n\f6 [245]", "text_norm": "7 twelfth schedule (as amended regulation 4 regulation (no 6) 2021) principal regulation amended entry medicinal product covid-19 vaccine astrazeneca suspension injection covid-19 vaccine (chadox1-s recombinant ) (inserted regulation 4 regulation 2021) substituting vaxzevria (also known covid19 vaccine astrazeneca) covid-19 vaccine astrazeneca place occurs given official seal 13 may 2021 stephen donnelly minister health 6 245", "start_char": 6826, "end_char": 7414, "source_path": "downloads\\2021\\2021_0245.pdf", "extraction_method": "pdfminer", "checksum": "sha256:dc8272cc533c74279613db122738a29b3d13e064612f3a11db39aecf8bc96504", "cross_refs": []}
{"doc_id": "si-2021-0245-explanatory-note", "parent_doc_id": "si-2021-0245", "section_id": "explanatory-note", "section_label": "EXPLANATORY NOTE", "si_number": "S.I. No. 245 of 2021", "title": "Medicines Board (Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the", "year": 2021, "heading": "(This note is not part of the Instrument and does not purport to be a legal", "text_raw": "EXPLANATORY NOTE \n\n(This note is not part of the Instrument and does not purport to be a legal \ninterpretation.) \n\nThese Regulations amend the Medicinal Products (Prescription and Control of \nSupply) Regulations 2003. \n\nThe purpose of these Regulations is to— \n\n(1) provide for the supply and administration of Covid-19 vaccines by \n\nadditional health care professionals, \n\n(2) provide for the administration of Covid-19 vaccines by health care \n\nstudents, and \n\n(3) update the name of the Covid-19 vaccination produced by AstraZeneca \n\nin the Eighth and Twelfth Schedules to the Regulations of 2003. \n\nThese Regulations may be cited as the Medicinal Products (Prescription and \nControl of Supply) (Amendment) (No. 7) Regulations 2021. \n\n \n \n \n \n \n \n \n \n \n \n \n\f[245] 7 \n\nBAILE ÁTHA CLIATH \nARNA FHOILSIÚ AG OIFIG AN tSOLÁTHAIR \nLe ceannach díreach ó \nFOILSEACHÁIN RIALTAIS, \n52 FAICHE STIABHNA, BAILE ÁTHA CLIATH 2, \nD02 DR67. \n\nTeil: 076 110 6834 \nr-phost: publications@opw.ie \n—————— \n\nDUBLIN \nPUBLISHED BY THE STATIONERY OFFICE \nTo be purchased from \nGOVERNMENT PUBLICATIONS, \n52 ST. STEPHEN'S GREEN, DUBLIN 2, \nD02 DR67. \n\nTel: 076 110 6834 \nE-mail: publications@opw.ie \n—————— \n\n€ 3.00 \n\n(DH-250) 75. 5/21. Propylon.", "text_norm": "explanatory note (this note part instrument purport legal interpretation.) regulation amend medicinal product (prescription control supply) regulation 2003 purpose regulation to-- (1) provide supply administration covid-19 vaccine additional health care professional (2) provide administration covid-19 vaccine health care student (3) update name covid-19 vaccination produced astrazeneca eighth twelfth schedule regulation 2003 regulation may cited medicinal product (prescription control supply) (amendment) (no 7) regulation 2021 245 7 baile atha cliath arna fhoilsiu ag oifig tsolathair le ceannach direach foilseachain rialtais 52 faiche stiabhna baile atha cliath 2 d02 dr67 teil 076 110 6834 r-phost publication opw.ie ------------ dublin published stationery office purchased government publication 52 st stephen green dublin 2 d02 dr67 tel 076 110 6834 e-mail publication opw.ie ------------ eur 3.00 (dh-250) 75 5 21 propylon", "start_char": 7414, "end_char": 8635, "source_path": "downloads\\2021\\2021_0245.pdf", "extraction_method": "pdfminer", "checksum": "sha256:dc8272cc533c74279613db122738a29b3d13e064612f3a11db39aecf8bc96504", "cross_refs": []}
